Rheumatic fever recurrence prevention: A nurse-led programme of 28-day penicillin in an area of high endemnicity

Journal of Paediatrics and Child Health

Volumn 47, Issue 4, 2011, Pages 228-234

  Spinetto, Heather ^a   Lennon, Diana ^b   Horsburgh, Margaret ^a  

^a Division of Medicine Emergency and Integrated Care   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

28 day penicillin prophylaxis; nurse led; rheumatic fever

Indexed keywords

BENZATHINE PENICILLIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; COMMUNITY HEALTH NURSING; DIAGNOSTIC ERROR; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NURSE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RHEUMATIC FEVER; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PENICILLINS; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 79955161798     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01942.x     Document Type: Article

References (35)

1. World Health Organization. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation. Geneva; 29 October 2004, 1 November 2001. Contract.
2. Bland EF, Duckett Jones T,. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation 1951; 4: 836-43.
3. Frankish JD,. Rheumatic fever prophylaxis: Gisborne experience. N.Z. Med. J. 1984; 97: 674-5. (Pubitemid 15222313)
4. Manyemba J, Mayosi BM,. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. 2004; 3: CD002227.
5. Tompkins D, Boxerbaum B, Liebman J,. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972; XLV: 543-51.
6. Strasser T,. Cost-effective control of rheumatic fever in the community. Health Policy 1985; 5: 159-64. (Pubitemid 16242070)
7. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN,. Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 1996; 97 (6 Pt 2): 984-8.
8. Committee on Infectious Diseases AAoP. Group A streptococcal infections. In:, Pickering LK, Baker CJ, Overturf GD, Prober CG, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove, CA: American Academy of Pediatrics, 2006; 610-20.
9. Berrios X, del Campo E, Guzman B, Bisno AL,. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults. Ann. Intern. Med. 1993; 118: 401-6. (Pubitemid 23081047)
10. Lennon D,. Rheumatic Fever Secondary Prophylaxis: Department of Health Circular; 1987. Report No.: HP 2/87. Contract.
11. Majeed HA, Khuffash FA, Yousof AM, et al,. The concurrent associations of group A streptococcal serotypes in children with acute rheumatic fever or pharyngitis-associated glomerulonephritis and their families in Kuwait. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene-series A, medical microbiology, infectious diseases, virology. Parasitology 1986; 262: 346-56.
12. North DA, Heynes RA, Lennon DR, Neutze J,. Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland [see comment]. N. Z. Med. J. 1993; 106: 400-3.
13. Grayson S, Horsburgh M, Lennon D,. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N. Z. Med. J. 2006; 119: U2255.
14. Special Writing Group. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. J. Am. Med. Assoc. 1992; 268: 2069-73.
15. Rutstein DDMD, Bauer WMD, Dorfman AMD, et al,. Jones criteria (modified) for guidance in the diagnosis of rheumatic fever: report of the Committee on Standards and Criteria for Programs of Care. Circulation 1956; 13: 617-20.
16. Atatoa-Carr P, Lennon D, Wilson N, New Zealand Rheumatic Fever Guidelines Writing Group. Rheumatic fever diagnosis, management, and secondary prevention: A New Zealand guideline. N. Z. Med. J. 2008; 121: 59-69. (Pubitemid 351818416)
17. World Health Organization. Community control of rheumatic heart disease in developing countries: 1. Strategies for prevention and control. WHO Chron. 1980; 34: 336-45.
18. Gordis L, Lilienfeld A, Rodriguez R,. An evaluation of the Maryland Rheumatic Fever Registry. Public Health Rep. 1969; 84: 333-9.
19. McDonald M, Brown A, Noonan S, Carapetis JR,. Preventing recurrent rheumatic fever: the role of register based programmes. Heart 2005; 91: 1131-3. (Pubitemid 41192376)
20. Baker M,. Rheumatic fever in New Zealand in 1990's: still cause for concern. N.Z. Public Health Rep. 1996; 3: 17-9.
21. Lue H, Hen C, Wei H,. Some problems in long-term prevention of streptococcal infection among children with rheumatic heart disease in Taiwan. Jpn. Heart J. 1976; 17: 550-9. (Pubitemid 8005792)
22. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN,. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J. Pediatr. 1994; 125 (5 Pt 1): 812-6.
23. Padmavati S,. Rheumatic fever and rheumatic heart disease in developing countries. Bull. World Health Organ. 1978; 56: 543-50. (Pubitemid 9017089)
24. Padmavati S, Gupta V, Prakash K, Sharma K,. Penicillin for rheumatic fever prophylaxis 3-weekly or 4-weekly schedule. J. Assoc. Physicians India 1987; 35: 753-5.
25. Sanyal S, Berry A, Duggal S, Hooja V, Ghosh S,. Sequelae of the initial attack of acute rheumatic fever in children from north India: A prospective 5 year follow-up study. Circulation 1982; 65: 375-9. (Pubitemid 12219034)
26. Strasser T, Dondog N, Kholy A, et al,. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull. World Health Organ. 1981; 59: 285-94. (Pubitemid 11035761)
27. Wood H, Feinstein A, Taranta A, Epstein J, Simpson R,. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann. Intern. Med. 1964; 60 (Suppl. 5): 31-46.
28. Newman JE, Lennon DR, Wong-Toi W,. Patients with rheumatic fever recurrences. N. Z. Med. J. 1984; 97: 678-80. (Pubitemid 15222315)
29. Kassem AS, Zaher SR, Abou Shleib H, El-Kholy AG, Madkour AA, Kaplan EL,. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two-week versus four-week regimens: comparison of two brands of BPG. Pediatrics 1996; 97: 992-95.
30. Lennon D, Stewart J, Farrell E, Palmer A, Mason H, Martin DR,. A RCT of a school-based primary prevention programme for rheumatic fever. Pediatr. Infect. Dis. J. 2009; 28: 787-94.
31. Iyengar SD, Grover A, Kumar R, Ganguly NK, Wahi PL,. Participation of health workers, school teachers and pupils in the control of rheumatic fever: evaluation of a training programme. Indian Pediatr. 1992; 29: 875-81.
32. Bisno A, Pearce I, Stollerman G,. Streptococcal infections that fail to cause recurrences of rheumatic fever. J. Infect. Dis. 1977; 136: 278-85. (Pubitemid 8170994)
33. Feinstein AR, Spagnuolo M, Levitt M, Jonas S, Tursky E,. Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. J. Am. Med. Assoc. 1966; 197: 949-52.
34. Johnson S, Streamer C, Williams P,. An evaluation of a streptococcal control program. Am. J. Public Health 1964; 54: 487-500.
35. Dajani AS, Bisno AL, Chung KJ, et al,. Prevention of rheumatic fever. Circulation 1988; 78: 1082-6.